Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nippon Shokubai
Osaka, Osaka, Japan
- Ownership
- Private
- Employees
- ~4685
- Development stage
- Other
01
Overview
Nippon Shokubai is a major global producer of acrylate/methacrylate monomers, adhesives, acrylic acids, superabsorbent polymers, specialty coatings ingredients, and, more recently, GMP-compliant nucleic acid drug APIs and regenerative medicine materials[5].
- Modalities
- Nucleic acid drug APIPolymer productsSuperabsorbent polymersMarine biodegradable plastics
- Industry
- Chemicals & Materials
02
Partnerships
Osaka University (academic, collaborative lab)Japanese and international universities, research institutes, and startups for open innovation
Beyond the preview
Go deeper on Nippon Shokubai.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nippon Shokubai.